Aggregate Spend Management & Disclosure
Complicating Factors and Leading Practices
Complicating Factors and Leading Practices
Effective interaction with stakeholders is critical to drug commercialisation
What next for the pharmaceutical industry?
New business models are needed for sustainable revenue growth
The Value of Early Commercialization
Necessary Burden or a Means to Enhancing Commercial Impact?
A Game-changer in the Health Care Industry
Alliance with Novo Oncology Associates facilitates collaboration